Skip to the content

Menu

Home
About
Products
- Hezkue
- Upcoming Products
Pipeline
Investors
Careers
Contact

Protected: Corporate Presentation

Post date January 15, 2020

Protected: Corporate Presentation

Protected: Corporate Presentation

Enter Password to Download:

Home
About
Products
Pipeline
Investors
Careers
Contact

Search for:

Recent Posts

Aspargo Labs Appoints Chief Marketing Officer
Aspargo Labs Announces Data on First Oral Spray for Erectile Dysfunction, ASP-001, Showing Two Times Faster Absorption Compared to Viagra® Tablets
Aspargo Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study
Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension
Aspargo Laboratories Announces IND Clearance by U.S. FDA, Enabling Launch of Bioequivalence and Food-Effect Studies for Sildenafil Oral Spray

Recent Comments

Archives

November 2024
June 2024
December 2023
September 2023
August 2023
January 2023
November 2022
October 2022
September 2022
June 2022
May 2022
May 2020

Categories

Press Release

Meta

Log in
Entries feed
Comments feed
WordPress.org

Facebook-f X-twitter Instagram Linkedin

17 State Street, Suite 3220, New York, NY 10004 | 646-503-1260

© 2024 Aspargo Labs, Inc. All rights reserved. Privacy Policy.

Home
About
Products
Pipeline
Investors
Careers
Contact

Home
About
Products
Pipeline
Investors
Careers
Contact